Evan Anderson, CEO and Board Member of Luma Therapeutics, has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
Kirsten Carroll holds over 15 years of experience in product development, marketing, strategy and business development for medical devices in stroke care. Currently VP for Strategic Development at The Stroke Project, she has held senior positions at Imperative Care and Stryker Neurovascular, where she built the Marketing Operations department into a nine-person strategic development team.
Michael Seres, founder and CEO of UK- and US- based 11 Health and Technologies, was the 11th Briton to receive an intestinal transplant. His company has developed a Bluetooth sensor and associated platform that allows patients with colostomies and similar conditions to monitor output and receive alerts when their medical bags need to be emptied.
Derek founded his company, Spinal Singularity, after he was shot by a sniper in Afghanistan and paralyzed from the chest down. Spinal Singularity's product, the Connected Catheter, enables people with spinal cord injuries and other conditions to control their urination wirelessly using a smartphone app.